Recent Investment Analysts’ Ratings Updates for Palomar (PLMR)

Palomar (NASDAQ: PLMR) has recently received a number of price target changes and ratings updates:

• 7/20/2026 – Palomar had its price target raised by JPMorgan Chase & Co. from $150.00 to $167.00. They now have an “overweight” rating on the stock.
• 7/15/2026 – Palomar had its price target raised by Piper Sandler from $132.00 to $165.00. They now have an “overweight” rating on the stock.
• 7/10/2026 – Palomar was given a new $152.00 price target by Evercore Inc.
• 7/8/2026 – Palomar had its price target raised by Keefe, Bruyette & Woods from $162.00 to $166.00. They now have an “outperform” rating on the stock.
• 6/18/2026 – Palomar was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 6/2/2026 – Palomar was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”.
• 5/26/2026 – Palomar had its price target lowered by JPMorgan Chase & Co. from $160.00 to $150.00. They now have an “overweight” rating on the stock.

Insider Buying and Selling

In other Palomar news, insider Timothy Carter sold 480 shares of Palomar stock in a transaction that occurred on Sunday, June 28th. The stock was sold at an average price of $124.29, for a total value of $59,659.20. Following the transaction, the insider directly owned 1,670 shares of the company’s stock, valued at $207,564.30. The trade was a 22.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Mac Armstrong sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $112.96, for a total value of $395,360.00. Following the completion of the sale, the chief executive officer owned 329,388 shares of the company’s stock, valued at $37,207,668.48. The trade was a 1.05% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 14,343 shares of company stock worth $1,812,773 in the last ninety days. 3.70% of the stock is owned by insiders.

Get Palomar Holdings Inc alerts:

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Featured Stories

• Five stocks we like better than Palomar
• Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
• Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
• Moog Is More Than a Missile Maker, and Wall Street Is Noticing
• A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Palomar Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.